← Leaderboards
Michael Farkas
Va Western New York Healthcare System
$2,087,981
Attributed
$2,087,981
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $346.5K · FY2010–24$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,087,981 · 3
VA$0 · 1
By mechanism
R01$1,590,395 · 1
R21$346,500 · 1
F32$151,086 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Retina”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,214,939
- Adam R Glassman · Jaeb Center For Health Research, Inc.$47,242,041
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Adam Glassman · Jaeb Center For Health Research, Inc.$31,583,813
- Karen J Cruickshanks · University Of Wisconsin Madison$28,499,261
Research focus
RetinaGenesAffectProteinsRetinal DegenerationBlindnessPathogenesisTissuesLeadGene TherapyMediatingCrispr/Cas TechnologyBaseIn VitroNovel StrategiesPhenotypeTranscriptome SequencingClinical TrialsPhotoreceptorsCellsGene ExpressionMutationInheritedAnimals
Grant awards (14)
Utilizing circular, self-amplifying RNAs for prolonged expression$346,500
R21 · FY2024 · EY · contact PI
Epigenetic-guided studies of AMD pathology and iPSC-RPE transplantation therapy$0
I01 · FY2023 · VA · contact PI
Using functional homology of RP1 isoforms to guide alternative therapeutic strategies$309,074
R01 · FY2022 · EY · contact PI
Epigenetic-guided studies of AMD pathology and iPSC-RPE transplantation therapy$0
I01 · FY2022 · VA · contact PI
Using functional homology of RP1 isoforms to guide alternative therapeutic strategies$309,075
R01 · FY2021 · EY · contact PI
Epigenetic-guided studies of AMD pathology and iPSC-RPE transplantation therapy$0
I01 · FY2021 · VA · contact PI
Using functional homology of RP1 isoforms to guide alternative therapeutic strategies$326,391
R01 · FY2020 · EY · contact PI
Epigenetic-guided studies of AMD pathology and iPSC-RPE transplantation therapy$0
I01 · FY2020 · VA · contact PI
Using functional homology of RP1 isoforms to guide alternative therapeutic strategies$323,556
R01 · FY2019 · EY · contact PI
Using functional homology of RP1 isoforms to guide alternative therapeutic strategies$322,299
R01 · FY2018 · EY · contact PI
The Role of RNA Splicing Factors in Retinal Degeneration$52,154
F32 · FY2012 · EY · contact PI
The Role of RNA Splicing Factors in Retinal Degeneration$30,751
F32 · FY2011 · EY · contact PI
The Role of RNA Splicing Factors in Retinal Degeneration$20,575
F32 · FY2011 · EY · contact PI
The Role of RNA Splicing Factors in Retinal Degeneration$47,606
F32 · FY2010 · EY · contact PI